YES1 Is a Druggable Oncogenic Target in SCLC
Author:
Funder
Research Directorate-General
Instituto de Salud Carlos III
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference45 articles.
1. Small-cell lung cancer: what we know, what we need to know and the path forward;Gazdar;Nat Rev Cancer,2017
2. Small-cell lung cancer;Rudin;Nat Rev Dis Primers,2021
3. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data;Rudin;Nat Rev Cancer,2019
4. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer;Horn;N Engl J Med,2018
5. Novel strategies for the treatment of small-cell lung carcinoma;William;Nat Rev Clin Oncol,2011
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recent advances in lung cancer organoid (tumoroid) research (Review);Experimental and Therapeutic Medicine;2024-08-01
2. Zinc finger protein 367 exerts a cancer-promoting role in small cell lung cancer by influencing the CIT/LATS2/YAP signaling cascade;Toxicology and Applied Pharmacology;2024-08
3. Adaptor protein CEMIP reduces the chemosensitivity of small cell lung cancer via activation of an SRC-YAP oncogenic module;Acta Pharmacologica Sinica;2024-07-23
4. Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer;Molecular Cancer;2024-02-24
5. Emerging Roles of YES1 in Cancer: The Putative Target in Drug Resistance;International Journal of Molecular Sciences;2024-01-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3